Cue Biopharma, Inc. insider trading activity

Understanding Insider Activity at Cue Biopharma, Inc.

Welcome to our dedicated page for Cue Biopharma, Inc. (Nasdaq: CUE) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Cue Biopharma, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Cue Biopharma, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for CUE
TickerTime & DateFilingLink
CUE09:00:04 PM, 12/18/2024
PASSERI DANIEL R(CHIEF EXECUTIVE OFFICER) purchased 30000 shares of Cue Biopharma, Inc. (CUE) for ~$30900
Filing
CUE08:08:25 PM, 08/29/2023
Suri Anish(PRESIDENT AND CSO) purchased 4000 shares of Cue Biopharma, Inc. (CUE) for ~$11040
Filing
CUE08:07:47 PM, 08/16/2023
PASSERI DANIEL R(CHIEF EXECUTIVE OFFICER) purchased 3000 shares of Cue Biopharma, Inc. (CUE) for ~$8580
Filing
CUE08:05:02 PM, 03/27/2023
Kiener Peter A sold 9325 shares of Cue Biopharma, Inc. (CUE) for ~$30585
Filing